StemiRNA Therapeutics Co., Ltd.
https://www.stemirna.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From StemiRNA Therapeutics Co., Ltd.
Chinese Biotechs' Foray Into mRNA Enters New Chapter With $100m Everest Deal
Everest Medicines’ deal with Canadian biotech Providence Therapeutics contains a full transfer of technology which may be appealing to Chinese regulators.
Junshi Joins China mRNA Mania Through Immorna JV
After immuno-oncology, mRNA is fast becoming a hot area in China as a flurry of biotechs from I-Mab to Kangtai partner with a little-known developer.
Newest Biotech Joins China mRNA COVID Vaccine Race
Additional Chinese coronavirus vaccine makers are now building up capacity, with Beijing-based AIM Vaccine preparing for a 400 million dose per year production capability for mRNA vaccines, while Chengdu-based Clover is to supply up to 414 million doses of its vaccines to GAVI.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Controlled Release
-
Biotechnology
- Antisense, Oligonucleotides
- Nanotechnology, Chips, etc.